Journal of Human Hypertension
The Journal of Human Hypertension is the official journal of the World Hypertension League. For author submission guidelines please visit the JHH website here.
The Journal of Human Hypertension became the official journal of WHL in March 2021, receiving an enthusiastic welcome from Prof. Michael Stowasser, Editor-in-Chief of JHH:
“As Editor-in-Chief of the Journal of Human Hypertension, I am very excited to see this partnership with the World Hypertension League come to fruition. It is a great honour to front the WHL’s flagship journal and to thereby assist in the dissemination of the League’s first class scientific communications. This relationship promises to be a real win-win for both the WHL and JHH and I am confident it will go from strength to strength over the coming years.”
Virginia Mercer, the publisher of JHH at Springer-Nature, added: “I am delighted that JHH has partnered with the WHL. It’s an exciting time for these two organizations and I’m particularly pleased that the journal can support WHL in all its great work.”
“As Editor-in-Chief of the Journal of Human Hypertension, I am very excited to see this partnership with the World Hypertension League come to fruition. It is a great honour to front the WHL’s flagship journal and to thereby assist in the dissemination of the League’s first class scientific communications. This relationship promises to be a real win-win for both the WHL and JHH and I am confident it will go from strength to strength over the coming years.”
Virginia Mercer, the publisher of JHH at Springer-Nature, added: “I am delighted that JHH has partnered with the WHL. It’s an exciting time for these two organizations and I’m particularly pleased that the journal can support WHL in all its great work.”
Prof. Xin-Hua Zhang, WHL’s Past President, stated: “It’s a high priority for WHL that its journal be accessible to authors worldwide to submit and publish their articles without charge, though authors will still retain the option to elect open access publishing should they wish to do so. We also hope that the journal will be accessible to readers worldwide and I am pleased that mechanisms to expand this access will be introduced steadily during the next several months. As a leading organization in the field of hypertension we look forward enthusiastically to working with the journal in disseminating critical messages and guidance to support our mission of advancing hypertension care in all parts of the World.”